Cost analysis of drug treatment in hypertensive patients at social security health care family medicine units.
Salud Publica Mex
; 64(2): 188-195, 2022 04 08.
Article
in En
| MEDLINE
| ID: mdl-35438925
OBJECTIVE: To estimate the increase of drug treatment costs associated with predictive factors of hypertensive patients in family medicine units. MATERIALS AND METHODS: A generalized linear model was employed to estimate costs with data from a microcosting costing study for a 1-year time horizon. Sources of dada were medical electronic files, phar-macy records and unitary prices updated to 2019. RESULTS: From a total of 864 patients older than 65 years were 67% and women 65%. Factors with most influence on mean drug treatment costs were diabetes, age and complications associ-ated with hypertension. Mean annual cost of antihypertensive treatment was 61 dollars (CI95% 55,67) and median were 32 dollars (IQR 30,35) per patient. Incremental costs for diabetes were 23 dollars (CI95% 13,33) and 25 dollars (CI95% 5,45) in the group of ≥ 65 years. CONCLUSION: Diabetes, age and complications were the factors with largest influence on hypertension pharmacological costs.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
Hypertension
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Salud Publica Mex
Year:
2022
Document type:
Article
Affiliation country:
Mexico
Country of publication:
Mexico